Combination of Alpelisib and Trametinib in Progressive Refractory Meningiomas: Phase 1 Study
Latest Information Update: 08 Aug 2024
At a glance
- Drugs Alpelisib (Primary) ; Trametinib (Primary)
- Indications Meningioma
- Focus Adverse reactions
- Acronyms ALTREM
Most Recent Events
- 06 Aug 2024 Planned End Date changed from 1 Sep 2022 to 29 Jan 2026.
- 06 Aug 2024 Planned primary completion date changed from 1 Sep 2022 to 29 Jan 2026.
- 29 Apr 2020 Planned End Date changed from 1 Jan 2022 to 1 Sep 2022.